Ananda Developments Plc to Attend Momentous Events Birmingham - 22nd September

The directors of the Company accept responsibility for the contents of this announcement.

Ananda Developments has been established as a company to invest in the developing market for medical or therapeutic Cannabis derivatives, or related products, including but not limited to nutraceuticals, dietary supplements and cosmetic products which contain Cannabis or hemp derived cannabinoids. The Directors believe that this market is growing due to an increasing number of states in the USA , as well as other countries around the world, changing their laws to allow for products containing constituents of Medical Cannabis to be developed, approved and sold.

A copy of the Company's Admission Document is available at http://www.anandadevelopments.com and at http://www.nexexchange.com.

Ananda's investment strategy is to invest in companies, projects or products that are either progressing medical or therapeutic Cannabis research and development, or are developing or have already developed, products that contain Cannabis derived cannabinoids and require funding to progress work plans or commercialise products.

http://www.anandadevelopments.com  

    
Ananda Developments Plc
Executive Director
Melissa Sturgess
Investor Relations 
+44(0)739 269 6517

Jeremy Sturgess-Smith
ir@anandadevelopments.com
Peterhouse Capital Limited
Corporate Finance

Fungai Ndoro
Mark Anwyl

Corporate Broker
Lucy Williams
Dunan Vasey   
+44(0)20-7469-0930

Celicourt Communications 
Joanna Boon
Mark Antelme 
+44(0)20-7520-9261